Document is current
Any future updates will be listed below
-
Authors
Pahmeier, Kathrin http://orcid.org/0000-0001-7259-5769
Neusser, Silke
Hamm, Christian
Kastner, Johannes
Wöhrle, Jochen
Zahn, Ralf
Achenbach, Stephan
Mehilli, Julinda
Gori, Tommaso
Naber, Christoph
Nef, Holger
Neumann, Till
Richardt, Gert
Schmermund, Axel
Claas, Christoph
Riemer, Thomas
Biermann-Stallwitz, Janine
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02066623 at ClinicalTrials.govDocuments that mention this clinical trial
Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry
https://doi.org/10.1186/s12872-022-02815-2
-
Funding
Funding for this research was provided by:
Abbott Vascular
Universität Duisburg-Essen
- License Information
-
More Information
Article History
Received: 31 October 2021
Accepted: 12 August 2022
First Online: 20 August 2022
Declarations
:
: Patients had to sign an informed consent form for inclusion. The study considered the Declaration of Helsinki and was approved by the ethics board of the University of Giessen.
: Not applicable.
: Mr. Gori received Speakers’ honoraria and research support from Abbott Vascular. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
